Drugmaker Eli Lilly told Business Insider in a statement that "anyone purporting to sell retatrutide for human use is breaking the law." The company added: "No one should consider taking anything claiming to be retatrutide outside of a Lilly-sponsored clinical trial." Still, the trend persists
Peptide May Prevent PAH, Rat Study Finds Written by | A peptide a short chain of amino acids, the building blocks of proteins called BPC 157 may prevent or counteract pulmonary arterial hypertension (PAH) and its complications, according to a preclinical study in a rat model of the disease
Can CFS overlap with fibromyalgia or other conditions
When your vitamin B12 level is low, your level of MMA rises
Further, a clinical trial of over 3,000 people living with type 2 diabetes and chronic kidney disease found that semaglutide led to improvement for kidney, cardiovascular, and survival outcomes including a 24% reduced risk of kidney disease events and18% lower risk of major cardiovascular events compared to placebo